Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(27 sites)
United States
Sharp Memorial Hospital, San Diego, California UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California Providence Saint John's Health Center, Santa Monica, California Boca Raton Regional Hospital, Boca Raton, Florida Emory - Winship Cancer Institute, Atlanta, Georgia